🐦 推特Andrew Feldman (Cerebras CEO)Codex · 实盘不做把握 7/10不做原因:无增量信息
北京时间·🕒 发布 08-24 21:05:00时区推断·⟳ 抓取 08-24 21:05:06·⚡ 决策 08-25 02:08:52 +5h03m·63.6 天前
Cerebras CEO谈AI抗癌和自动驾驶长期愿景，但未披露公司经营增量
事件是CEO观点类社媒内容，不是Cerebras或相关公司的经营公告；没有订单、合作、收入、监管准入、产品商业化或指引变化，无法形成正期望交易。
📄 原文Andrew Feldman (Cerebras CEO)@andrewdfeldman↗ 原文
We have a chance for our children to grow up and never know anyone who died from cancer. That is a real achievable goal…
不做 Cerebras Systems（CBRS.US）
不做Cerebras Systems（CBRS.US）：本帖只是CEO长期愿景表达，没有公司级新增经营事实、量级或预期差。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Andrew Feldman的帖子强调AI在生命科学和自动驾驶上的长期价值，但没有把Cerebras Systems（CBRS.US）的技术、客户、收入或市场份额推到新状态；直接载体扫描也没有发现会改变可交易性的替代证券。因此不做。
🔎 新鲜度:最早出现 2026-08-24 · 扩散 low · price-in 风险 low ↗
消息传播链
- Cerebras CEO发布AI长期社会价值观点，未披露公司经营增量。
主要风险
- 若后续出现Cerebras与Mayo Clinic、UK Biobank、药企或自动驾驶客户的正式合同、收入里程碑或指引变化，需要重新研究。
- 当前事件没有量级句可计算，因为原文未披露金额、客户、商业化路径或经济权益。
反向证据
- 做多前查反向 · 来源 source_text · 日期 2026-08-24 · 影响 weakens
原文未出现订单、合作、收入指引、客户采购承诺或产品商业化新增事实。
检索:Andrew Feldman Cerebras cancer AI drug discovery self-driving order partnership revenue guidance 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例不足强化不做结论：不能把长期AI叙事映射成短线买入Cerebras Systems（CBRS.US）或相关主题股。
方向:没有可用于定价的同市场同机制先例，因为当前事件不是订单、产品发布、监管批准或财务指引。
涨幅量级:无高相似先例可校准涨跌幅。
形态:观点类社媒帖缺少可量化催化，历史事件研究不适合作为交易幅度依据。
原文全文
展开原文 · 989 字
We have a chance for our children to grow up and never know anyone who died from cancer.
That is a real achievable goal in the next 25 years.
There's plenty of data in biology and life sciences:
Mayo Clinic has records on millions of patients.
The UK Biobank has over a billion images from medical scans.
For the first time, we have a tool that can analyze it all.
Pancreatic cancer just had a huge breakthrough.
The opportunity for discoveries like that has never been better.
And it goes beyond cancer.
Cancer is the #1 killer of middle-aged adults.
Road accidents are the #1 killer of young people worldwide.
AI-driven drug discovery will take on the first.
Self-driving cars take on the second.
Remove those two and you'd look back and say: that was a pretty good 20-year run of technology.
Writing better code is cool, and there's a huge market for it.
But when I think about what we're all doing this for - it's an outcome like this.
Thanks to @MollySOShea for having me on.
That is a real achievable goal in the next 25 years.
There's plenty of data in biology and life sciences:
Mayo Clinic has records on millions of patients.
The UK Biobank has over a billion images from medical scans.
For the first time, we have a tool that can analyze it all.
Pancreatic cancer just had a huge breakthrough.
The opportunity for discoveries like that has never been better.
And it goes beyond cancer.
Cancer is the #1 killer of middle-aged adults.
Road accidents are the #1 killer of young people worldwide.
AI-driven drug discovery will take on the first.
Self-driving cars take on the second.
Remove those two and you'd look back and say: that was a pretty good 20-year run of technology.
Writing better code is cool, and there's a huge market for it.
But when I think about what we're all doing this for - it's an outcome like this.
Thanks to @MollySOShea for having me on.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。